The saga of Once Upon a Time in Shaolin, the one-of-a-kind Wu-Tang Clan album that Martin “pharma bro” Shkreli bought for ...

The price tag behind the government's sale of Wu-Tang Clan's Once Upon a Time in Shaolin album has been revealed. According ...

After years of pursuing the unredacted records, Leopold finally got them last week. The government sold “Once Upon a Time in ...

After several years of trying to obtain the paperwork, the U.S. Marshals Service finally gave a copy of the bill of sale and ...

Martin Shkreli infamously jacked up the price of the life-saving drug Daraprim. Getty Images. In addition to the ban, Shkreli was found liable for $64.6 million in penalties related to his effort ...

Martin Shkreli, controversial drug CEO, arrested for fraud 02:32. For many social media users, Martin Shkreli's arrest Thursday on charges of securities fraud is cause for holiday cheer.

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs after a hearing at U.S. Federal Court in Brooklyn, New York, June 26, 2017.

Martin Shkreli, the disgraced former CEO and hedge fund manager derisively known as "Pharma Bro," was released early from a Pennsylvania federal prison Wednesday, according to multiple outlets.

Martin Shkreli, center, leaves the courthouse after his arraignment in New York, Dec. 17, 2015. Seth Wenig/AP Photo — -- CEO is a title Martin Shkreli can no longer list on his business cards.

Federal prosecutors allege Shkreli lied and stole to keep his other companies afloat Pharmaceutical CEO Martin Shkreli who was accused of price gouging is out on bail after his arrest Thursday on ...